These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35282364)

  • 1. Heart Failure Risk Predictions and Prognostic Factors in Adults With Congenital Heart Diseases.
    Leczycki P; Banach M; Maciejewski M; Bielecka-Dabrowa A
    Front Cardiovasc Med; 2022; 9():692815. PubMed ID: 35282364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of confirmed and potential predictors of an unfavorable outcome in heart failure in everyday clinical practice.
    Chuda A; Banach M; Maciejewski M; Bielecka-Dabrowa A
    Ir J Med Sci; 2022 Feb; 191(1):213-227. PubMed ID: 33595788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide, Troponin-T, and Growth-Differentiation Factor 15 in Adult Congenital Heart Disease.
    Baggen VJ; van den Bosch AE; Eindhoven JA; Schut AW; Cuypers JA; Witsenburg M; de Waart M; van Schaik RH; Zijlstra F; Boersma E; Roos-Hesselink JW
    Circulation; 2017 Jan; 135(3):264-279. PubMed ID: 27832613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High sensitivity troponin T in adult congenital heart disease.
    Rybicka J; Dobrowolski P; Lipczyńska M; Kowalik E; Klisiewicz A; Hoffman P; Szymański P
    Int J Cardiol; 2015 Sep; 195():7-14. PubMed ID: 26011405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetrical dimethylarginine--more sensitive than NT-proBNP to diagnose heart failure in adults with congenital heart disease.
    Tutarel O; Denecke A; Bode-Böger SM; Martens-Lobenhoffer J; Lovric S; Bauersachs J; Schieffer B; Westhoff-Bleck M; Kielstein JT
    PLoS One; 2012; 7(3):e33795. PubMed ID: 22470476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiopoietin-2 in adults with congenital heart disease and heart failure.
    Lukasz A; Beutel G; Kümpers P; Denecke A; Westhoff-Bleck M; Schieffer B; Bauersachs J; Kielstein JT; Tutarel O
    PLoS One; 2013; 8(6):e66861. PubMed ID: 23826161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Prognostic Value of Novel Markers in Adults With a Systemic Right Ventricle.
    Geenen LW; van Grootel RWJ; Akman K; Baggen VJM; Menting ME; Eindhoven JA; Cuypers JAAE; Boersma E; van den Bosch AE; Roos-Hesselink JW
    J Am Heart Assoc; 2019 Sep; 8(17):e013745. PubMed ID: 31431113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.
    Eindhoven JA; van den Bosch AE; Ruys TP; Opić P; Cuypers JA; McGhie JS; Witsenburg M; Boersma E; Roos-Hesselink JW
    J Am Coll Cardiol; 2013 Sep; 62(13):1203-12. PubMed ID: 23916937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication.
    Diller GP; Dimopoulos K; Okonko D; Li W; Babu-Narayan SV; Broberg CS; Johansson B; Bouzas B; Mullen MJ; Poole-Wilson PA; Francis DP; Gatzoulis MA
    Circulation; 2005 Aug; 112(6):828-35. PubMed ID: 16061735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-sensitive troponin-T in adult congenital heart disease.
    Eindhoven JA; Roos-Hesselink JW; van den Bosch AE; Kardys I; Cheng JM; Veenis JF; Cuypers JAAE; Witsenburg M; van Schaik RHN; Boersma E
    Int J Cardiol; 2015 Apr; 184():405-411. PubMed ID: 25746495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the Ability index superior to the NYHA classification for assessing heart failure?: comparison of two classification scales in adolescents and adults with operated congenital heart defects.
    Norozi K; Wessel A; Buchhorn R; Alpers V; Arnhold JO; Zoege M; Geyer S
    Clin Res Cardiol; 2007 Aug; 96(8):542-7. PubMed ID: 17593319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New York Heart Association (NYHA) classification in adults with congenital heart disease: relation to objective measures of exercise and outcome.
    Bredy C; Ministeri M; Kempny A; Alonso-Gonzalez R; Swan L; Uebing A; Diller GP; Gatzoulis MA; Dimopoulos K
    Eur Heart J Qual Care Clin Outcomes; 2018 Jan; 4(1):51-58. PubMed ID: 28950356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation Between New York Heart Association Functional Class and Objective Measures of Cardiopulmonary Exercise in Adults With Congenital Heart Disease.
    Das BB; Young ML; Niu J; Mendoza LE; Chan KC; Roth T
    Am J Cardiol; 2019 Jun; 123(11):1868-1873. PubMed ID: 30954207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronotropic incompetence in adolescents and adults with congenital heart disease after cardiac surgery.
    Norozi K; Wessel A; Alpers V; Arnhold JO; Binder L; Geyer S; Zoege M; Buchhorn R
    J Card Fail; 2007 May; 13(4):263-8. PubMed ID: 17517345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal ventilatory response to exercise in adults with congenital heart disease relates to cyanosis and predicts survival.
    Dimopoulos K; Okonko DO; Diller GP; Broberg CS; Salukhe TV; Babu-Narayan SV; Li W; Uebing A; Bayne S; Wensel R; Piepoli MF; Poole-Wilson PA; Francis DP; Gatzoulis MA
    Circulation; 2006 Jun; 113(24):2796-802. PubMed ID: 16769913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotype, management and predictors of outcome in a large cohort of adult congenital heart disease patients with heart failure.
    Van De Bruaene A; Hickey EJ; Kovacs AH; Crean AM; Wald RM; Silversides CK; Redington AN; Ross HJ; Alba AC; Billia F; Nair K; Benson L; Horlick E; Osten M; Colman J; Heggie J; Oechslin EN; Roche SL
    Int J Cardiol; 2018 Feb; 252():80-87. PubMed ID: 29103857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise testing for assessment of heart failure in adults with congenital heart disease.
    Burstein DS; Menachem JN; Opotowsky AR
    Heart Fail Rev; 2020 Jul; 25(4):647-655. PubMed ID: 31686282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Role of Blood and Urine Biomarkers in the Clinical Care of Adults with Congenital Heart Disease.
    Rajpal S; Alshawabkeh L; Opotowsky AR
    Curr Cardiol Rep; 2017 Jun; 19(6):50. PubMed ID: 28432659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of galectin-3 in adults with congenital heart disease.
    Baggen VJM; van den Bosch AE; Eindhoven JA; Menting ME; Witsenburg M; Cuypers JAAE; Boersma E; Roos-Hesselink JW
    Heart; 2018 Mar; 104(5):394-400. PubMed ID: 28942393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery.
    Norozi K; Wessel A; Alpers V; Arnhold JO; Geyer S; Zoege M; Buchhorn R
    Am J Cardiol; 2006 Apr; 97(8):1238-43. PubMed ID: 16616033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.